NDC 24201-500

Ganciclovir

Ganciclovir

Ganciclovir is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Leucadia Pharmaceuticals. The primary component is Ganciclovir Sodium.

Product ID24201-500_8c6aaaac-7654-1ad8-e053-2995a90af844
NDC24201-500
Product TypeHuman Prescription Drug
Proprietary NameGanciclovir
Generic NameGanciclovir
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2019-11-20
Marketing CategoryANDA / ANDA
Application NumberANDA212001
Labeler NameLeucadia Pharmaceuticals
Substance NameGANCICLOVIR SODIUM
Active Ingredient Strength500 mg/10mL
Pharm ClassesCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 24201-500-25

25 VIAL in 1 CARTON (24201-500-25) > 15 mL in 1 VIAL (24201-500-01)
Marketing Start Date2019-11-20
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
GANCICLOVIR SODIUM500 mg/10mL

Pharmacological Class

  • Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
  • DNA Polymerase Inhibitors [MoA]
  • Nucleoside Analog [EXT]
  • Nucleoside Analog Antiviral [EPC]

NDC Crossover Matching brand name "Ganciclovir" or generic name "Ganciclovir"

NDCBrand NameGeneric Name
14335-030Ganciclovirganciclovir sodium
25021-185ganciclovirganciclovir sodium
42023-173GanciclovirGanciclovir
51754-2500GANCICLOVIRGANCICLOVIR
51817-171Ganciclovirganciclovir sodium
63304-636GANCICLOVIRGANCICLOVIR
63304-637GANCICLOVIRGANCICLOVIR
63323-315GanciclovirGANCICLOVIR SODIUM
70436-089Ganciclovirganciclovir sodium
24201-500GanciclovirGanciclovir
24208-535ZIRGANganciclovir

© 2019 FDA.report
This site is not affiliated with or endorsed by the FDA.